The import of composite diagnostic or laboratory reagents to Canada exhibited a moderate upward trend from 2013 to 2023, reaching $785.25 million in 2023. The year-on-year variation was mostly positive, with notable growth periods from 2018 to 2023, where the increase in imports paced at around 1.52% annually for 2023 and a compound annual growth rate (CAGR) of 1.36% over the last five years. Despite some fluctuations, the long-term outlook from 2024 to 2028 anticipates continued growth with a forecasted 1.08% annual increase, equating to a 5.52% rise over the five-year period.
Future trends to watch for include:
- The impact of technological advancements in diagnostic reagents on import volume and value.
- Potential shifts in demand due to changes in healthcare policy or emerging health conditions.
- Exchange rate fluctuations that might affect cost and affordability of imports.
- Evolving trade agreements or regulations influencing import dynamics.
